Anzeige
Mehr »
Sonntag, 07.06.2026 - Börsentäglich über 12.000 News
Breaking News: Nasdaq Quantencomputer Play mit riesigem Kurspotential!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41NVB | ISIN: US5240382052 | Ticker-Symbol:
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
AIMWELL PARTNERS INC Chart 1 Jahr
5-Tage-Chart
AIMWELL PARTNERS INC 5-Tage-Chart

Aktuelle News zur AIMWELL PARTNERS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoAimwell Partners: AimwellBio Opens a Door Most People Will Not Be Allowed Through, And Healthcare's Sharpest Professionals Are Already Walking In238A new professional intelligence network is forming around the people who shape clinical, research, regulatory, and capital decisions. Observer access is free. The credentialing is not. And the first...
► Artikel lesen
27.05.Aimwell Partners: Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself387DENVER, CO / ACCESS Newswire / May 27, 2026 / Aimwell Bio (OTC:AIMN) today issued commentary on what the company believes is an emerging shift within healthcare and biopharma infrastructure: the rise...
► Artikel lesen
20.05.Aimwell Partners: The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI419DENVER, CO / ACCESS Newswire / May 20, 2026 / Aimwell Partner, (OTC:AIMN) and it's brand, AimwellBio today released the following industry brief examining the growing shift within healthcare toward...
► Artikel lesen
18.05.Aimwell Partners: Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians392DENVER, CO / ACCESS Newswire / May 18, 2026 / AimwellBio, operating through Aimwell Partners Inc. (OTCID:AIMN), appears to have structured its platform architecture around a question increasingly being...
► Artikel lesen
13.05.Aimwell Partners: The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For.300DENVER, CO / ACCESS Newswire / May 13, 2026 / Aimwell Partners Inc. (OTCID:AIMN) today confirmed the next phase of expansion across the AimwellBio verified intelligence platform: new indication coverage...
► Artikel lesen
11.05.Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones259DENVER, CO / ACCESS Newswire / May 11, 2026 / Aimwell Partners (OTCID:AIMN) Brand, AimwellBio announced continued progress across its live demonstration, onboarding, and framework development initiatives...
► Artikel lesen
06.05.Aimwell Partners: While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn't.286AimwellBio's live signal intelligence engine is now tracking 13 source streams in real time - FDA actions, drug recalls, clinical trials, patent filings, global outbreaks, and regulatory divergence....
► Artikel lesen
04.05.Aimwell Partners: AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape242NEW YORK CITY, NY / ACCESS Newswire / May 4, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today announced that initial engagement with hospital systems and hospitalists has...
► Artikel lesen
AIMWELL PARTNERS Aktie jetzt für 0€ handeln
27.04.Aimwell Partners: AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings286Aimwell Partners Inc. (OTC:AIMN) expands its healthcare intelligence platform to address one of the fastest-growing risks in modern medicine - clinical decisions influenced by unverified or AI-generated...
► Artikel lesen
22.04.Aimwell Partners: Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure294MIAMI, FL / ACCESS Newswire / April 22, 2026 / Aimwell Partners (OTC pink:AIMN) Aimwell Bio today announced a material expansion of engagement across the healthcare ecosystem, with active deployment...
► Artikel lesen
20.04.Aimwell Partners: Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network ; Tackles 38% AI Hallucination Rate in Biopharma220MIAMI, FL / ACCESS Newswire / April 20, 2026 / Aimwell Partners (OTC Pink:AIMN) Aimwell Bio today officially opened applications for its exclusive Founding Cohort, a high-fidelity intelligence network...
► Artikel lesen
15.04.Aimwell Partners: AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio502AI is making life-or-death decisions in healthcare, and nobody is checking if the answers are real. AimwellBio is the first platform that does. FHIN founding cohort now forming. MIAMI, FL / ACCESS Newswire...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1